Judge Orders $245M In Guardant Damages In DNA Patent Suit
A judge has boosted what Guardant Health Inc. owes in a case in which it was found to have infringed two TwinStrand Biosciences Inc. patents covering methods of lowering the error...To view the full article, register now.
Already a subscriber? Click here to view full article